Health Condition 1: N181- Chronic kidney disease, stage 1 Health Condition 2: N182- Chronic kidney disease, stage 2 (mild) Health Condition 3: N183- Chronic kidney disease, stage 3 (moderate)
Conditions
Interventions
Intervention1: Safoof-e-Indrijulab: 6 capsules filled with Safoof-e-Indrijulab of 500mg with milk in the morning after food. (Total 3 gm/day). For 42 days
Control Intervention1: Safoof-e-Shora Qalmi:
Sponsors
National Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1.Diagnosed cases of CKD stage 1 to 3b associated with or without hypertension and/or diabetes mellitus on treatment 2.eGFR >=30- 3.Sr. creatinine level >= 1.1- 4.Patients who will give consent and able to do follow up
Exclusion criteria
Exclusion criteria: 1.Urine albumin > 2+ ( > 300 mg/L) (Reagent strip urinalysis) 2.Patient with BP >140/90 mm Hg while taking 4 or more anti-hypertensive agents 3.Patients with HbA1c > 8% 4.Presence of urinary red cell casts, RBC > 20/hpf 5.H/O recurrent or extensive nephrolithiasis 6.Hereditary kidney disease 7.Severe systemic illness 8.Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Improvement in eGFR 2.Reduction in Sr. creatinine Timepoint: 0th, 7th, 14th, 21st, 28th, 35th, 42nd day | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
Public ContactAmmara Gharatkar
National Institute of Unani Medicine
Outcome results
None listed